Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on October 16, 2026

8 hours ago

Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy

Indeterminate GlobeNewswire

8 hours ago

hear.com Receives 2026 Global Recognition Award for Hearing Care Innovation

Indeterminate GlobeNewswire

8 hours ago

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

Indeterminate GlobeNewswire

8 hours ago

twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes

Indeterminate GlobeNewswire

8 hours ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

Indeterminate GlobeNewswire

9 hours ago

Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types

Indeterminate GlobeNewswire

9 hours ago

Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

9 hours ago

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Indeterminate GlobeNewswire

9 hours ago

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Indeterminate GlobeNewswire

9 hours ago

Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease

Indeterminate GlobeNewswire

13 hours ago

Senturi Pharma announces exclusive European distribution agreement for PERTZYE®

Indeterminate GlobeNewswire

13 hours ago

Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology

Indeterminate GlobeNewswire

14 hours ago

Microbiotica Raises £36 Million ($48 Million) in Series C Financing to Advance Pipeline into Phase 2 Clinical Development

Indeterminate GlobeNewswire

15 hours ago

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

Indeterminate GlobeNewswire

17 hours ago

City Therapeutics Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire